Insilico Medicine (“Insilico”), a clinical-stage end-to-end generative artificial intelligence (AI) drug discovery company, has achieved a significant breakthrough in the application of multiple generative AI models and AlphaFold structures for drug discovery.
Clade I Mpox Surge in the Congo Raises Concerns About Global Spread
The increasing number of suspected clade I mpox virus cases in the Democratic Republic of the Congo (DRC) poses a global threat for potential spread,
May 17, 2024